Study Findings: Moving the Dial in Lowering and Controlling A1C


Truven Health Analytics, part of the IBM Watson Health company business, conducted an analysis for Welldoc by using the MarketScan Research Databases, a family of research data sets that fully integrate de-identified patient-level health data, productivity, laboratory results, health risk assessments, hospital discharges, electronic medical records, and morbidity data into data available for healthcare research.

Data are contributed by large employers, managed care organizations, hospitals, electronic-medical-record providers, and Medicare and Medicaid programs. Findings are based on an analysis of commercial and Medicare consumers within the MarketScan databases. Truven Health researchers created a complex, custom algorithm and applied it to the MarketScan data. Welldoc also applied the Truven Health findings to previous research it conducted about the Welldoc BlueStar solution’s ability to lower and control A1C.

The information we provide at is not medical advice, nor is it intended to replace a consultation with a medical professional. Please inform your physician of any changes you make to your diet or lifestyle and discuss these changes with them. If you have questions or concerns about any medical conditions you may have, please contact your physician.

Request our full clinical reference list at email.


Break down care access barriers and deliver the tools and knowledge so people can self-manage their chronic conditions.

Welldoc’s chronic care management platform helps impact cost and health outcomes.

Subscribe to Our Newsletter


Taking Diabetes Self-Management to the Next Level